NEWTON, Mass.--(BUSINESS WIRE)--Pro-Pharmaceuticals, Inc. (Amex: PRW), a company “Advancing Drugs Through Glycoscience®”, today reported its second quarter and six months financial results, ended June 30, 2007. For the second quarter of 2007, the Company reported net income of $36,000, or $0.00 per share, basic and fully diluted, compared with net income of $230,000, or $0.01 per share basic or ($0.03) per share fully diluted, for the same period in 2006. Approximately $1,819,000 of the second quarter results were non-cash expenses relating to the change in fair value of the convertible debentures and warrant liabilities compared with $2,868,000 in the second quarter of 2006.
